Fundraising Fox

Joris Vanderlocht

Investor

Partner and Chief Scientific Officer at Bioqube Ventures

Houthalen, Flemish Region, Belgium

About

Joris Vanderlocht is Partner and CSO at Bioqube Ventures, joining in 2018 with over 15 years in academic and translational immunology covering cancer immunotherapy, autoimmunity, and immune deficiencies. He leads scientific diligence, supports portfolio companies and venture creation, and drives translational research toward early clinical development.

LinkedIn ↗

Invests in

BiotechMedical Devices

Experience

  1. Bioqube VenturesPartner and CSOcurrent2025 — presentHasselt, Flemish Region, Belgium
  2. Bioqube VenturesChief scientific advisor2022 — 2025Mechelen, Flemish Region, Belgium
  3. Bioqube VenturesSenior Business Analyst2018 — 2022Beerse, Belgium
  4. Stealth NewCoBoard directorcurrent2025 — present
  5. Commit BiologicsBoard Observer2021 — 2024
  6. Primmune TherapeuticsBoard Observer2020 — 2024
  7. Spica TherapeuticsBoard Observer2021 — 2023
  8. UHasseltResearch Scientist2018 — 2022Hasselt, Belgium
  9. Maastricht UMC+Laboratory specialist Medical Immunology at the Central Diagnostic Laboratory2017 — 2018Maastricht Area, Netherlands
  10. Maastricht university medical centerStafmember Tissue Typing and Transplantation Immunology2011 — 2017Maastricht Area, Netherlands
  11. Maastricht university medical centerPostdoctoral researcher2006 — 2011
  12. Fred HutchResident in transplantation immunology2015Greater Seattle Area
  13. UCLA Department of Microbiology, Immunology and Molecular GeneticsResident in Transplantation Immunology2014Los Angeles
  14. Hasselt UniversityPhD student2001 — 2006

Education

  1. Convent medische immunologie (CMI), The NetherlandsMedical immunologist2014 — 2017
  2. SMBWO, The NetherlandsSMBWO certified Immunologist2006 — 2014
  3. Hasselt UniversityPhD, Immunology2001 — 2006
  4. Catholic University of LeuvenMSc, Biochemistry1999 — 2001
  5. Hasselt UniversityBSc, Biology1997 — 1999

Skills & more

pre-clinical development1Oncology1Biotechnology1Flow Cytometry8tissue typingMolecular & Cellular BiologyImmunology12Immunohistochemistry4Cell Culture4Molecular Biology6Cell Biology5Lifesciences
+12 moreELISAStem CellsPCRqPCRScienceGeneticsFACSBiochemistryCancerDNADNA sequencingGenomics

Languages English · French

From Joris's professional profile.

Same school

Also attended Hasselt University8

Katleen VandersmissenManaging Partner at Heran PartnersReginald VossenBestuurder - Voorzitter at AngelwiseHarry De SmedtIC at AngelwiseNico VandervelpenManaging Partner at Bioqube VenturesKatleen VandersmissenAdvisory Board Expert at Qbic FundPhilippe StasInvestor at White Fund

+ 2 more

Shared employers

Also worked at Bioqube Ventures14

Debora DumontManaging Partner at Bioqube VenturesDirk ReynManaging Partner at Bioqube VenturesNico VandervelpenManaging Partner at Bioqube VenturesJoris De MaeyerExecutive in Residence at Bioqube VenturesAlexander DemoulinAssociate at Bioqube VenturesRoderick VerhelstPrincipal at Bioqube Ventures

+ 8 more

Also worked at Primmune Therapeutics3

Debora DumontManaging Partner at Bioqube VenturesTom HeymanExecutive Partner at Bioqube VenturesAiden AcevesVice President at Insight Partners

Also worked at Spica Therapeutics3

Debora DumontManaging Partner at Bioqube VenturesAlexander DemoulinAssociate at Bioqube VenturesGeert TackaertFinance Director at Bioqube Ventures

Also worked at UHasselt2

Debora DumontManaging Partner at Bioqube VenturesGeert HoubenVenture Partner at RDY Ventures

Colleagues at Bioqube Ventures

Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures